An Indian researcher at the Centre for
Cellular and Molecular Biology (CCMB) in Hyderabad believes that he and
members of his former group “narrowly missed” this year’s Nobel Prize
for medicine.
The Prize, announced on Monday at
Stockholm, s shared by Americans Andrew Fire and Craig Mello for their
discovery of silencing genes by a method known as “RNA inference” or
RNAi. The technique has opened new paths to treating and even preventing
a disease by switching off the gene responsible for it by introducing
small strands of custommade RNA molecules.
Utpal Bhadra, a CCMB scientist, said his
group – which included his wife Monika and James Birchler at the
University of Missouri in the US – was one of the first to work on gene
silencing but narrowly missed the Nobel race.
Bhadra said that while working at the
University of Missouri his group showed how to silence genes in fruit
flies for the first time. He joined the CCMB in 2001.
“We made the discovery by accident,” Bhadra
said in a telephonic interview, adding that the finding laid one of the
foundations for RNAi. They published their findings in 1997 in cell, a
prestigious journal. Fire and Mello, selected for this year’s Nobel
Prize, demonstrated gene silencing in nematode worms called ‘C.elegans’.
They pushed their findings in 1998, a year after the publication by
Bhadra’s team. “I think Bhadra’s team missed it narrowly,” CCMB director
Lalji Singh said. Fire has himself acknowledged the Bhadra group’s
contribution in a message that says: “While we got the Nobel Prize,
there are a lot of giant discoveries and you are part of that.”
Bhadra said his group was initially in the
panel under consideration by the Nobel committee but was eventually
dropped “as there were too many players”. While claiming it was
delighted that this year’s Nobel gave recognition to the field of
research he and his wife – both Well-come Trust Fellows – are working
on. While he is working on how to use the gene silencing technique to
prevent AIDS and Japanese encephalitis, his wife Monika at the Indian
Institute of Chemical Technology, also in Hyderabad, is focussing on
using this method to prevent cancer. Bhadra’s group has used this
technique, with funding from the Silk Board, to create transgenic
silkworms resistant to viral diseases. Lalji Singh said that Bhadra’s
work on HIV and other viral diseases would speed up once his institute
completes construction of the special containment facility for handling
infectious organisms in the next two months.
Click here for source
No comments :
Post a Comment
Thank you for your comments.